Iron overload and chronic hepatitis C: The role of HFE gene mutations;Sobrecarga férrica y hepatitis crónica C: Papel de las mutaciones del gen HFE

Revista Espanola de Enfermedades Digestivas

Volumn 95, Issue 12, 2003, Pages 819-828

  Garcia Buey L ^b   Gonzalez Mateos F ^a  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; FERRITIN; HFE PROTEIN; IRON; TRANSFERRIN RECEPTOR;

ALCOHOL CONSUMPTION; AUTOIMMUNE HEPATITIS; BLOOD TRANSFUSION; DNA POLYMORPHISM; EDITORIAL; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HEPATITIS C; HEPATITIS C VIRUS; HETEROZYGOSITY; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; IRON STORAGE; KUPFFER CELL; LIVER CELL; LIVER DISEASE; LIVER NECROSIS; LIVER TOXICITY; PROTEIN FUNCTION;

HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON OVERLOAD; MEMBRANE PROTEINS; MUTATION;

EID: 0347135901     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (37)

1. Bonkovsky HL, Banner BF, Lambrecht RW, Robin RB. Iron in liver diseases other than hemocromatosis. Semin Liver Dis 1996; 16: 65-81.
2. Harrison SA, Bacon BR. Hederitary haemocromatosis: update for 2003. J Hepatol 2003; 38: S14-S23.
3. Bonkovsky HL, Troy N, McNeal K, Banner BF, Sharma A, Obando J, et al. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. J Hepatol 2002; 37: 848-54.
4. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurement of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102: 2108-43.
5. Ioannou GN, Tung BY, Kowdley KV. Iron in hepatitis C: villain or innocent bystander? Semin Gastrointest Dis 2002; 13: 95-108.
6. Arber N, Konikoff FM, Moshkowitz M. Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases. Dig Dis Sci 1994; 39: 2656-9.
7. Riggio O, Montagnese F, Fiore P, Folino S, Giambartolomei S, Gandin C, et al. Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol 1997; 92: 1298-301.
8. Beinker NK, Voigt MD, Arendse M, Smit J, Stander IA, Kirsch RE. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 1996; 25: 633-8.
9. Thorburn D, Curry G, Spooner R, Spence E, Oien K, Halls D, et al. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 2002; 50: 248-52.
10. Ladero JM, Ropero P, Ortega L, Taxonera C, González FA, López-Alonso G, et al. Mutaciones del gen HFE, contenido hepático de hierro y gravedad histológica en la hepatitis crónica por el virus de la hepatitis C. Rev Esp Enferm Dig 2003; 95 (12): 829-32.
11. Bacon BR, Britton RS. The pathology of hepatic iron overload: a free radical-mediated process? Hepatology 1990; 11: 127-37.
12. Britton RS. Metal induced hepatotoxicity. Semin Liver Dis 1996; 16: 3-12.
13. Pietrangelo A. Iron oxidative stress and liver fibrogenesis. J Hepatol 1998; 28 (Supl. 1): 8-13.
14. Bonkovsky HL, Lambrecht RW. Iron induced liver injury. Clin Liver Dis 2000; 4: 409-29.
15. Walker EM, Walker S. Effects of iron overload on the immune system. Ann Clin Lab Sci 2000; 30: 354-65.
16. Seligman PA, Kovar J, Gelfand EW. Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways. Pathobiology 1992; 60: 19-26.
17. Chapoutot C, Esslimani M, Joomaye Z. Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis. Gut 2000; 46: 711-4.
18. Fernández LI, García Buey L, Moreno Otero R. Alteraciones del metabolismo del hierro en la hepatitis crónica C. Rev Esp Enferm Dig 1999; 91: 583-9.
19. Kakizaki S, Tagaki H, Horiguchi N. Iron enhances hepatitis C virus replication in cultured human hepatocytes. Liver 2000; 20: 125-8.
20. Haque S, Chandra B, Gerber M, Lok S. Iron overload in patients with chronic hepatitis C: a clinicopahological study. Hum Pathol 1996; 27: 1277-81.
21. Ludwig J, Hashimoto E, Porrayko M. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997; 122: 882-8.
22. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class-I like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-409.
23. Sánchez M, Villa M, Ingelmo M, Sanz C, Bruguera M, Ascaso C, Oliva R. Population screening for hemochromatosis: a study in 5370 spanish blood donors. J Hepatol 2003; 38: 745-50.
24. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000; 33: 485-504.
25. Piperno A, Fargion S, D'Alba. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol 1992; 16: 364-8.
26. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. J Hepatol 2003; 39: 620-7.
27. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology 1998; 27: 1661-9.
28. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CD, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996; 335: 1799-805.
29. Smith BC, Grove J, Guzuil M, Day CP, Daly AR, Burt AD, Bassendine M. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998; 27: 1695-9.
30. Martinelli AL, Franco RF, Villanova MG, Figueiredo JF, Secaf M, Tavella MH, et al. Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection? Act Haematol 2000; 102: 152-6.
31. Pirisi M, Scott CA, Avellini C, Toniutto P, Fabris C, Soardo G, et al. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation and HFE missense mutations. Am J Clin Pathol 2000; 113: 546-54.
32. Negro F, Samii K, Rubbia-Brandt L, Quadri R, Male PJ, Zarski JP, et al. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis. J Med Virol 2000; 60: 21-7.
33. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, Kaserer K, Hackl F, Polli C, et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999; 116: 127-34.
34. Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV. Hepatitis C, iron status and disease severity: relationship with HFE mutations. Gastroenterology 2003; 124: 318-28.
35. Hezode C, Cazeneuve C, Coue O, Roudot-Thoraval F, Lonjou Y, Bastie A, et al. Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations in patients with chronic hepatitis C. J Hepatol 1999; 31: 979-84.
36. Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takimoto R, et al. Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 2001; 61: 8697-702.
37. Yano M, Hayashi H, Wakusawa S, Sanae F, Takikawa T, Shiono Y, et al. Long term effects of phelobotomy on biochemical and histological parameters of chronic hepatitis C. Am J Gastroenterol 2002; 97: 133-7.